Necroptosis plays dual roles in cancer: it acts as a tumor suppressor in colorectal and hepatocellular carcinomas (101–107), where RIPK3/MLKL downregulation correlates with poor prognosis, but may promote inflammation-driven malignancy in specific contexts (108–113). This evidence concerns the gene MLKL and neoplasm.